Development of new antimalaria strategies and particularly vaccines, needs an in-depth
understanding of the relationships between transmission, infection, immunity, morbidity and …

Six hundred eighty-nine Plasmodium falciparum malaria attacks were observed during a
three-year period among 226 inhabitants of the village of Dielmo, Senegal, an area of high …

Significant progress has been made in the development of the malaria vaccine during the
last 20 years. Ninety percent of the 300–500 million clinical cases of malaria per year …

Quel critère utiliser pour le diagnostic des accès palustres dans les centres de santé des
zones d'endémie? Comment mettre au point un algorithme clinique pour prendre en charge …

The SPf66 synthetic vaccine is safe and partly efficacious against Plasmodium falciparum
malaria among children 1–5 years old. The estimated vaccine efficacy [VE] for all clinical …

Between July 2000 and June 2001, we used weekly active case detection (ACD) of clinical
malaria episodes in 618 children aged< 5 years to describe the epidemiology of malaria in …

Il n'existe pas de signe pathognomonique du paludisme. Les accès de fièvre, l'anémie, les
signes de gravité comme le coma ou les détresses respiratoires ne peuvent être aisément …

The aim of this study was to highlight the high degree of clinical resistance of P. falciparum
and also of P. vivax to chtoroquine and also the importance of early diagnosis and prompt …

Se estima que el tamaño del genoma de variasespecies dePlasrnodiurn es de
aproximadamente 2-4 x 1 O'pares de bases. Cerca de 10% del genomade las formas …

Résumé La perspective d'une vaccination antipalustre a, depuis 20 ans, suscité bien des
espoirs et finalement surtout engendré le doute et la déception. Si la plupart des tentatives …